CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials Prospective Elimination of Distal Coronary Sinus to Left Atrial Connection for Atrial Fibrillation Ablation (PRECAF) Randomized Controlled Trial The HACD4 haplotype as a risk factor for atherosclerosis in males Long-term Survival following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-On Study) Spontaneous Coronary Artery Dissection: JACC State-of-the-Art Review Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD Stent fracture is associated with a higher mortality in patients with type-2 diabetes treated by implantation of a second-generation drug-eluting stent
|<<... 3 4 5 6 7 8 9 ...>>|

Clinical TrialVolume 13, Issue 9, May 2020

JOURNAL：JACC: Cardiovascular Interventions Article Link

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

RA Buiten, EH Ploumen, P Zocca et al. Keywords: zotarolimus-eluting stent; ZES; sirolimus-eluting stent; SES; TVF

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top